IvyRock Asset Management HK Ltd purchased a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm purchased 6,000 shares of the exchange traded fund’s stock, valued at approximately $732,000. SPDR S&P Biotech ETF makes up 0.4% of IvyRock Asset Management HK Ltd’s investment portfolio, making the stock its 10th largest position.
Other large investors have also added to or reduced their stakes in the company. Legacy Wealth Managment LLC ID acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $32,000. Ballast Advisors LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $36,000. Creative Financial Designs Inc. ADV acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $39,000. Barnes Dennig Private Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $48,000. Finally, Navalign LLC acquired a new position in SPDR S&P Biotech ETF during the 4th quarter worth $48,000.
SPDR S&P Biotech ETF Price Performance
Shares of XBI stock opened at $133.42 on Friday. SPDR S&P Biotech ETF has a 1-year low of $80.90 and a 1-year high of $139.19. The firm has a fifty day moving average of $131.81 and a two-hundred day moving average of $126.55. The firm has a market cap of $8.51 billion, a P/E ratio of 11.47 and a beta of 0.85.
SPDR S&P Biotech ETF Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Further Reading
- Five stocks we like better than SPDR S&P Biotech ETF
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
